How I Test: Measurable Residual Disease Testing For ALL
Dr. Stock will provide a case based presentation on the impact of measuring residual disease (MRD) in patients with ALL. The discussion will include review of the prognostic impact of MRD in adults with both Ph- and Ph+ ALL, the optimal time(s) for measurement, how MRD is being used to assess treatment and inform transplant options and will touch on the current methods of assessment of MRD.
Active, International, Emeritus, and Honorary Members
Associate, International Associate, Student, and Resident Members